FMT v Fidaxomicin v Vancomycin for Multiply Recurrent CDI (Provider)
Fecal Microbiota Transplantation Efficacy References:
1. Hvas C et al. “Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile
Infection” Gastroenterology 156 (5) 1324 -1332. 2019
DISCLAIMER:The comments made during these videos are offered only for general informational and educational purposes. Dr. Feuerstadt's comments are not offered as and do not constitute medical advice or legal opinions and no statement made during these videos is intended to replace your independent and professional judgment.